ascopubs.org

Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors (NETs): A sequential case series.

Comparison of concurrent chemoradiation with stereotactic body radiation therapy versus conventionally fractionated radiation therapy following induction chemotherapy for unresected locally advanced ...
ascopubs.org

Impact of Ga-68 DOTATATE imaging on clinical management of neuroendocrine tumor patients: Post-FDA-approval analysis of first 200 clinical patients.

The spectrum of activating EGFR mutations from cell-free DNA (cfDNA) in large pancreatic cancer cohort. This is an ASCO Meeting Abstract from the 2019 Gastrointestinal Cancers Symposium. This abstract ...
News Medical

Ga-68 DOTATATE PET/CT scans more effective than current imaging standard for detecting NETS

A recent study reported in the May issue of the Journal of Nuclear Medicine demonstrates that Ga-68 DOTATATE PET/CT scans are superior to In-111 pentetreotide scans, the current imaging standard in ...
EurekAlert!

PET/CT provides superior lesion detection for head and neck paragangliomas compared to gold standard MRI

Toronto, Ontario—A novel imaging approach— 68 Ga-DOTATATE PET/CT—can more accurately differentiate residual/recurrent tumors from post-surgery scar tissue in patients with head and neck paragangliomas ...
Science Daily

Better way to diagnose, manage neuroendocrine tumors

Ga-68 DOTATATE PET/CT scans are superior to In-111 pentetreotide scans, the current imaging standard in the United States for detecting neuroendocrine tumors (NETS), and could significantly impact ...
Healio

Imaging agent effectively detects, localizes tumors in Cushing’s syndrome

Please provide your email address to receive an email when new articles are posted on . In a retrospective review, Richard Auchus, MD, PhD, professor of pharmacology and internal medicine in the ...
News Medical

Advanced imaging kit Netspot gets FDA approval to detect rare neuroendocrine tumors

The U.S. Food and Drug Administration today approved Netspot, the first kit for the preparation of gallium Ga 68 dotatate injection, a radioactive diagnostic agent for positron emission tomography ...
Medscape

Neuroendocrine Tumors Can't Hide From DOTATATE PET

June 21, 2012 (Miami Beach, Florida) — Molecular imaging with a method that detects hormonally active tissues in the body can improve the care of patients with neuroendocrine cancer, researchers said ...
Newswire

AAA Receives Orphan Drug Designation from FDA and EMA for Gallium-68 DOTATATE for Use in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors

SAINT-GENIS-POUILLY, France, March 4, 2014 /CNW/ - Advanced Accelerator Applications (AAA), a fast growing international player in Molecular Nuclear Medicine (MNM), announced today that they have ...
Scoop

Game-Changer In Cancer Care: Mobile Imaging Brings Gallium-68 Dotatate PET-CT Scans To Patients

Access to advanced diagnostic imaging has taken a significant leap forward with the introduction of Gallium-68 Dotatate PET-CT scans now available through Mobile Imaging's mobile service. Starting ...
Healio

FDA approves imaging agent to detect neuroendocrine tumors

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio The FDA approved Netspot, the first kit ...
Medindia

AAA Receives Orphan Drug Designation from FDA and EMA for Gallium-68 DOTATATE for Use in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors

Advanced Accelerator Applications (AAA), a fast growing international player in Molecular Nuclear Medicine (MNM), announced today that they have received orphan drug designation status for their ...